Each week (well almost, some weeks are quite uneventful), we compile and curate hot-off-the-press news and updates on the happenings in the world of pharma and life sciences partnering.
Be sure to follow us and keep up-to-date on all things partnering to inform your decisions and strategies.
Medison Pharma Ltd. announced today an exclusive multi-regional agreement with Argenx to commercialize efgartigimod in 14 countries, across Europe and Israel, for the treatment of adult patients with generalized myasthenia gravis – see full article.biospace.com
Soleo Health, provider of specialty pharmacy services, announced it was named one of only four limited distribution drug (LDD) specialty pharmacy partners to dispense nationwide RADICAVA ORS® (edaravone) oral suspension, commercialized by Mitsubishi Tanabe Pharma America, Inc. (MTPA) – see full article.businesswire.com
After layoffs and reshuffling of its R&D leadership, Agios is preparing for a new approach to innovation via business development and partnerships to advance its programs – see full article.fiercebiotech.com
Owkin, with its artificial intelligence-powered clinical development platform, signs another pharma partner – Bristol-Myers Squibb; the deal is split between a Series B financing led by BMS and upfront fees of $80 million – see full article.pharmaphorum.com
Dren Bio announces $65 Million Series B financing – with Pfizer as one of its marquee investors – to take its lead asset into the clinic and accelerate development of new product candidates from its targeted Myeloid Engager and Phagocytosis Platform – see press release.drenbio.com
Vipergen, provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced multi-target drug discovery partnership with LEO Pharma focused on novel treatments for dermatology indications – see full article.prnewswire.com
Boehringer Ingelheim announced the signing of an option to acquire Trutino Biosciences Inc. , a San Diego-based pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases – see press release.boehringer-ingelheim.com
Humanigen, a late-stage clinical biopharmaceutical company, and PCI Pharma Services, a global contract development and manufacturing organization (CDMO) , announced an agreement for commercialization of lenzilumab, a first-in-class monoclonal antibody that has been shown to neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF) associated with COVID-19 and other indications – see full article.biopharminternational.com
The University of Texas MD Anderson Cancer Center, Invectys and the Cell Therapy Manufacturing Center (CTMC) have entered a strategic partnership to co-develop a compliant and mountable process for human leukocyte antigen (HLA)-G targeted chimeric antigen receptor (CAR) T cell therapy to treat solid tumours – see full article.pharmaceutical-technology.com
Valneva SE, a specialty vaccine company, and Pfizer Inc. announced the closing of the equity investment where Pfizer has invested €90.5 ($95) million in Valneva, representing 8.1% of Valneva’s share capital at a price of €9.49 per share – see press release.pfizer.com
Sanyou Biopharmaceuticals, focused on R&D and services of innovative antibody drugs, and Dragon Sail Pharmaceutical, a CDMO and CMO enterprise providing high-end biological drug manufacture services, announced a long-term strategic partnership – see full article.prnewswire.com
Biogen and Happify Health announced a collaboration to provide a digital solution for patient education and engagement, powered by artificial intelligence (AI), to support people living with multiple sclerosis (MS) – see press release.investors.biogen.com
Inozyme Pharma, Inc., a clinical-stage rare disease company developing novel therapeutics for the treatment of abnormal mineralization, announced a partnership with Rady Children’s Institute for Genomic Medicine to advance and evaluate a novel newborn screening technology to facilitate diagnosis of genetic diseases – see full article.stemcellsciencenews.com